The EIC Accelerator is a highly competitive program that supports deeptech startups, including those in the biotech and AI sectors. The venture's focus on predicting drug resistance mutations aligns with the program's goals, and the founder's background in pharmacy and ML engineering makes them a strong candidate. The program's non-dilutive funding of up to €2.5M would be a significant boost to the venture's development.